Clinical Trial Update: SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study [Phase 4]

View source ↗

Summary

This update pertains to the Phase 4 SAFE study (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) for Peripheral Arterial Disease; the curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Sarpogrelate Anplone (sarpogrelate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Peripheral Arterial Disease | Phase 4 | Status: UNKNOWN